Multiple Sclerosis Relapse
24 drugs79,114 FAERS reportsMedDRA PT
GET
/api/v1/reaction/multiple-sclerosis-relapseReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Multiple Sclerosis Relapse (24)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Teriflunomide5,22512%
- 2Natalizumab16,8589.4%
- 3Fingolimod7,8029.0%
- 4Glatiramer5,3408.6%
- 5Diroximel Fumarate9538.3%
- 6Interferon Beta-1a15,8268.3%
- 7Peginterferon Beta-1a9697.5%
- 8Ozanimod5777.2%
- 9Interferon Beta-1b1,3427.1%
- 10Dalfampridine4,7666.7%
- 11Dimethyl Fumarate8,0976.6%
- 12Corticotropin706.6%
- 13Siponimod5326.0%
- 14Ofatumumab1,6615.1%
- 15Cladribine4685.1%
- 16Alemtuzumab9074.7%
- 17Ocrelizumab2,6694.4%
- 18Baclofen3,4073.9%
- 19Monomethyl Fumarate333.7%
- 20Amantadine5682.9%
- 21Ponesimod92.8%
- 22Modafinil8642.7%
- 23Ublituximab902.5%
- 24Quinidine812.1%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Multiple Sclerosis17 shared · 0.71
- Hypoaesthesia16 shared · 0.20
- Memory Impairment10 shared · 0.16
- Lymphocyte Count Decreased4 shared · 0.13
- Balance Disorder7 shared · 0.12
- Muscular Weakness8 shared · 0.11
- Gait Disturbance23 shared · 0.11
- Central Nervous System Lesion2 shared · 0.08
- Urinary Tract Infection11 shared · 0.08
- Influenza Like Illness4 shared · 0.07
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.